95% CI, 0.58-1.14) and for death as a competing event (HR, 0.82
Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y
Quality Control
Once started, the cascade becomes a vicious cycle that is self-sustaining unless an external factor intervenes to break the cycle
While a guest on the "Club Shay Shay" podcast, Iglesias explained why he ditched the GLP-1 that seemed to be working: "The problem with Ozempic is you're going to lose more muscle than fat." A 2024 review in Diabetes, Obesity, and Metabolism supports his assertion to an extent, stating that studies show GLP-1 use may cause the loss of up to 60% of a person's total lean muscle
[Crossref] [PubMed] Do D, Lee T, Peasah SK, et al